WENDY AWA: Open Payments
NPI 1770090789 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,487 in 43 payments from 11 companies in 2025. Trend: 2023 $1,891 · 2024 $1,363 · 2025 $1,487
Food & beverage: $1,487
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $322 |
| Alnylam Pharmaceuticals Inc. | 3 | $271 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $165 |
| Abbott Laboratories | 2 | $159 |
| PFIZER INC. | 6 | $149 |
| E.R. Squibb & Sons, L.L.C. | 5 | $139 |
| Lilly USA, LLC | 1 | $124 |
| Actelion Pharmaceuticals US, Inc. | 2 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: JARDIANCE, AMVUTTRA, WAINUA, CARDIOMEMS, VYNDAQEL, CAMZYOS, UPTRAVI, Kerendia.
Industry payments across CT — which companies pay providers there.
